Yasi Xu

522 total citations
23 papers, 354 citations indexed

About

Yasi Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yasi Xu has authored 23 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Yasi Xu's work include Lung Cancer Treatments and Mutations (8 papers), RNA modifications and cancer (5 papers) and Ferroptosis and cancer prognosis (3 papers). Yasi Xu is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), RNA modifications and cancer (5 papers) and Ferroptosis and cancer prognosis (3 papers). Yasi Xu collaborates with scholars based in China and United States. Yasi Xu's co-authors include Shirong Zhang, Lucheng Zhu, Jingjing Zhang, Nengming Lin, Yuqing Wang, Wenwen Wang, Dan Su, Bo Zhang, Dan Zhang and Jianguo Feng and has published in prestigious journals such as Cancer Letters, Journal of Thoracic Oncology and Journal of Cellular and Molecular Medicine.

In The Last Decade

Yasi Xu

21 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasi Xu China 10 178 116 83 69 64 23 354
Xinmei Li China 11 188 1.1× 78 0.7× 85 1.0× 41 0.6× 47 0.7× 19 313
Pimpisa Teeyakasem Thailand 10 160 0.9× 86 0.7× 67 0.8× 69 1.0× 16 0.3× 25 303
Shidong Lv China 10 252 1.4× 111 1.0× 97 1.2× 74 1.1× 14 0.2× 25 386
Yong Luo China 13 250 1.4× 73 0.6× 157 1.9× 82 1.2× 22 0.3× 31 398
Qiuyun Guo China 9 157 0.9× 59 0.5× 57 0.7× 56 0.8× 16 0.3× 13 309
Libo Si China 14 296 1.7× 60 0.5× 128 1.5× 76 1.1× 36 0.6× 29 406
Linlin Sun China 14 211 1.2× 41 0.4× 91 1.1× 85 1.2× 20 0.3× 25 459
Xiaowei Meng China 10 159 0.9× 100 0.9× 84 1.0× 61 0.9× 30 0.5× 27 303
Liz J. Hernández Borrero United States 2 260 1.5× 68 0.6× 120 1.4× 136 2.0× 14 0.2× 2 441
Lizhong Zeng China 12 189 1.1× 58 0.5× 99 1.2× 60 0.9× 13 0.2× 24 299

Countries citing papers authored by Yasi Xu

Since Specialization
Citations

This map shows the geographic impact of Yasi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasi Xu more than expected).

Fields of papers citing papers by Yasi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasi Xu. The network helps show where Yasi Xu may publish in the future.

Co-authorship network of co-authors of Yasi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yasi Xu. A scholar is included among the top collaborators of Yasi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasi Xu. Yasi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Linling, Yasi Xu, Yanyan Zhao, Bing Xia, & Lucheng Zhu. (2025). Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients. Cancer Immunology Immunotherapy. 74(11). 334–334.
2.
Xu, Yasi, Pengjun Zhao, Xiao Xu, et al.. (2024). T790M mutation sensitizes non-small cell lung cancer cells to radiation via suppressing SPOCK1. Biochemistry and Biophysics Reports. 38. 101729–101729. 4 indexed citations
3.
Zhang, Dan, et al.. (2023). Risk factors for thrombocytopenia in patients receiving linezolid therapy: a systematic review and meta-analysis. European Journal of Clinical Pharmacology. 79(10). 1303–1314. 16 indexed citations
4.
Wang, Wenwen, Weilong Li, Lingjie Li, et al.. (2023). Dynamic Regulation Genes at Microtubule Plus Ends: A Novel Class of Glioma Biomarkers. Biology. 12(3). 488–488. 2 indexed citations
5.
Wang, Wenwen, Jingjing Zhang, Yuqing Wang, Yasi Xu, & Shirong Zhang. (2022). Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment. Computational and Structural Biotechnology Journal. 20. 3322–3335. 49 indexed citations
6.
7.
Zhang, Jingjing, Qiong Wu, Lucheng Zhu, et al.. (2021). SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer. Cancer Letters. 524. 268–283. 59 indexed citations
8.
Wu, Kan, Xueqin Chen, Jianguo Feng, et al.. (2021). Capilliposide C from Lysimachia capillipes Restores Radiosensitivity in Ionizing Radiation-Resistant Lung Cancer Cells Through Regulation of ERRFI1/EGFR/STAT3 Signaling Pathway. Frontiers in Oncology. 11. 644117–644117. 5 indexed citations
9.
10.
11.
Xu, Yasi, Dan Su, Lucheng Zhu, et al.. (2018). S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1. Journal of Ovarian Research. 11(1). 39–39. 23 indexed citations
12.
Zhao, Yanyan, Shirong Zhang, Zhibing Wu, et al.. (2017). P2.05-029 Microwave Thermal Therapy Enhances Radiosensitivity of Highly Invasive Human Non-Small Cell Lung Cancer H460 Cells via Inhibiting DNA Repair. Journal of Thoracic Oncology. 12(1). S1048–S1048. 2 indexed citations
13.
Xu, Yasi, Shirong Zhang, Bing Xia, Lucheng Zhu, & Shenglin Ma. (2017). P2.05-005 Mechanism of Radiotherapy in Reduction/Delay of T790M-Mediated EGFR TKI Resistance. Journal of Thoracic Oncology. 12(1). S1033–S1033. 1 indexed citations
14.
Feng, Xing, Lucheng Zhu, Xiaoling Xiong, et al.. (2017). Therapeutical effect of intrapleural perfusion with hyperthermic chemotherapy on malignant pleural effusion under video-assisted thoracoscopic surgery. International Journal of Hyperthermia. 34(4). 479–485. 9 indexed citations
15.
Lopez, Hector Sanchez, Luca Zilberti, Oriano Bottauscio, et al.. (2017). Controlled E-peak field gradient coil. 2 indexed citations
16.
Zhu, Lucheng, Shirong Zhang, Jing Zhang, et al.. (2017). P2.03b-015 Efficacy of the Irreversible ErbB Family Blocker Afatinib in Treatment of an Intracerebral Non-Small Cell Lung Cancer in Mice. Journal of Thoracic Oncology. 12(1). S942–S942. 1 indexed citations
17.
Zhang, Shirong, Lucheng Zhu, Jing Zhang, et al.. (2016). Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice. Acta Pharmacologica Sinica. 38(2). 233–240. 32 indexed citations
18.
Zhang, Shirong, Yasi Xu, Lucheng Zhu, et al.. (2016). Capilliposide from Lysimachia capillipes inhibits AKT activation and restores gefitinib sensitivity in human non-small cell lung cancer cells with acquired gefitinib resistance. Acta Pharmacologica Sinica. 38(1). 100–109. 15 indexed citations
19.
Zhang, Chong, Jing Shi, Yasi Xu, et al.. (2014). Role of p38 MAPK in enhanced human cancer cells killing by the combination of aspirin and ABT‐737. Journal of Cellular and Molecular Medicine. 19(2). 408–417. 31 indexed citations
20.
Xu, Yasi, Jianguo Feng, Dan Zhang, et al.. (2013). S-allylcysteine, a garlic derivative, suppresses proliferation and induces apoptosis in human ovarian cancer cells in vitro. Acta Pharmacologica Sinica. 35(2). 267–274. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinmei Li Breakdown of academic impact, for papers by Pimpisa Teeyakasem Breakdown of academic impact, for papers by Shidong Lv Breakdown of academic impact, for papers by Yong Luo Breakdown of academic impact, for papers by Qiuyun Guo Breakdown of academic impact, for papers by Libo Si Breakdown of academic impact, for papers by Linlin Sun Breakdown of academic impact, for papers by Xiaowei Meng Breakdown of academic impact, for papers by Liz J. Hernández Borrero Breakdown of academic impact, for papers by Lizhong Zeng
Rankless by CCL
2026